Loading: 100%
Laboratory Corp. of America Holding logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter Burlington, United States of AmericaBurlington, United States of Americano data available
Employees 52,000 (as per Q1 2017)no data available
Sector Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available
Ticker LHno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17120132144156168
datesClosing price (adj.)
13.10.2017149.60
11.10.2017149.28
04.10.2017152.18
27.09.2017149.47
20.09.2017154.15
13.09.2017155.21
06.09.2017158.48
30.08.2017153.84
23.08.2017153.66
16.08.2017156.44
09.08.2017157.75
02.08.2017159.85
26.07.2017161.17
19.07.2017155.01
12.07.2017152.45
05.07.2017153.33
27.06.2017150.30
20.06.2017144.45
13.06.2017141.64
06.06.2017139.29
30.05.2017138.52
23.05.2017139.70
16.05.2017138.14
09.05.2017142.03
02.05.2017141.07
25.04.2017138.88
18.04.2017142.19
11.04.2017143.34
04.04.2017143.51
28.03.2017142.91
21.03.2017142.47
14.03.2017143.09
07.03.2017142.09
28.02.2017142.26
21.02.2017139.64
14.02.2017135.88
07.02.2017130.60
31.01.2017134.21
24.01.2017133.04
17.01.2017133.99
10.01.2017132.06
03.01.2017129.07
27.12.2016128.69
19.12.2016127.82
12.12.2016129.15
05.12.2016125.25
28.11.2016125.71
21.11.2016126.12
14.11.2016127.50
07.11.2016125.14
31.10.2016125.34
24.10.2016139.67
17.10.2016135.97
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
149.60n/a
Market Capitalisation
in million USD
15,304n/a
Enterprise Value
in million USD
20,923n/a
Common Shares Outstanding
as per Apr 26, 2017
102,300,000n/a
Preferred Shares Outstanding
as per Apr 26, 2017
n/a
Average Basic Shares Outstanding
TTM
102,725,000n/a
Average Diluted Shares Outstanding
TTM
104,475,000n/a
Index Membership
n/a
Business Summary
Laboratory Corp of America Holdings is a healthcare diagnostics company. It is engaged in providing comprehensive clinical laboratory and end-to-end drug development services.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 9,514n/a
Gross Profit 3,133n/a
Operating Income 1,331n/a
EBITDA 1,818n/a
Net Profit 657n/a
Balance Sheet
Cash and Cash Equivalents 568n/a
Receivables 1,347n/a
Total Current Assets 2,655n/a
PP&E 1,731n/a
Total Assets 14,483n/a
Accounts Payable 455n/a
Current Debt 698n/a
Total Current Liabilities 1,912n/a
Long-Term Debt 5,473n/a
Total Liabilities 8,944n/a
Total Equity 5,539n/a
Cash Flow
Depreciation & Amortisation 487n/a
Change in Working Capital -156n/a
Operating Cash Flow 1,112n/a
Net Change in PP&E and Intangibles -266n/a
Investing Cash Flow -705n/a
Dividends Paid 0n/a
Financing Cash Flow -542n/a
Total Change in Cash -146n/a
Free Cash Flow 1,043n/a
Profitability Ratios
Gross Margin 32.9%n/a
Operating Margin 14.0%n/a
Net Profit Margin 6.9%n/a
Return on Equity 11.9%n/a
Return on Assets 4.5%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA 11.51n/a
EV/Sales 2.20n/a
Book to Market Value 0.36n/a
Other Ratios
Current Ratio 138.8%n/a
Liabilities to Equity Ratio 161.5%n/a
Debt to Assets Ratio 42.6%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
4,068
4,505
4,695
5,004
5,542
5,671
5,808
6,012
8,680
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-2,377
-2,631
-2,724
-2,906
-3,268
-3,422
-3,585
-3,809
-5,777
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
1,691
1,874
1,971
2,098
2,275
2,250
2,223
2,203
2,903
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-864
-993
-1,022
-1,107
-1,245
-1,201
-1,211
-1,275
-1,787
Selling, General & Administrative
-809
-935
-959
-1,034
-1,160
-1,115
-1,129
-1,198
-1,622
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
-55
-58
-63
-73
-86
-86
-82
-77
-165
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
828
881
949
991
1,029
1,049
1,013
928
1,117
Non-Operating Income (Loss)
25
-57
-51
-63
-82
-79
-75
-84
-271
Interest Expense, net
-57
-72
-63
-70
-88
-95
-97
-110
-275
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
5
3
2
1
1
1
2
1
2
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
78
14
14
11
10
21
17
14
10
Other Non-Operating Income (Loss)
-1
-2
-4
-5
-6
-7
2
10
-8
Pretax Income (Loss), Adjusted
853
824
898
928
947
970
937
845
846
Abnormal Gains (Losses)
-51
-38
-14
-12
-81
-25
-22
-18
-114
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
802
786
885
916
866
944
916
827
732
Income Tax (Expense) Benefit, net
-326
-308
-329
-344
-333
-359
-340
-314
-294
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
477
478
556
572
533
585
575
513
438
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
477
478
556
572
533
585
575
513
438
Minority Interest
0
-13
-12
-13
-13
-2
-2
-1
-1
Net Income
477
465
543
558
520
583
574
511
437
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
477
465
543
558
520
583
574
511
437
Remarks
restated on Feb 24, 2010 n/a
calculated values,
restated on Mar 7, 2011 n/a
calculated values,
restated on Feb 24, 2012 n/a
calculated values,
restated on Feb 26, 2013 n/a
calculated values,
restated on Feb 25, 2014 n/a
calculated values,
restated on Feb 26, 2015 n/a
calculated values,
restated on Mar 1, 2016 n/a
calculated values,
restated on Mar 1, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
220
149
231
159
467
404
580
716
Cash & Cash Equivalents
n/a
220
149
231
159
467
404
580
716
Short Term Investments
n/a
0
0
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
632
574
656
700
719
785
816
1,218
Accounts Receivable, Net
n/a
632
574
656
700
719
785
816
1,218
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
91
90
103
111
121
137
140
191
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
91
123
154
90
86
107
158
496
Prepaid Expenses
n/a
84
80
96
80
75
107
158
339
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
7
43
58
11
11
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
157
Total Current Assets
n/a
1,033
936
1,144
1,060
1,392
1,432
1,693
2,621
Property, Plant & Equipment, Net
n/a
496
501
587
578
631
707
787
1,747
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
3,140
3,401
4,457
4,474
4,772
4,826
4,823
9,709
Intangible Assets
n/a
1,223
1,342
1,674
1,621
1,668
1,572
1,476
3,332
Goodwill
n/a
1,772
1,897
2,601
2,682
2,902
3,023
3,099
6,166
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
2
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
72
71
79
77
78
89
93
58
Miscellaneous Long Term Assets
n/a
74
91
103
94
125
143
155
150
Total Noncurrent Assets
n/a
3,637
3,902
5,044
5,052
5,403
5,534
5,609
11,457
Total Assets
n/a
4,670
4,838
6,188
6,112
6,795
6,966
7,302
14,078
Liabilities and owners' equity
Payables & Accruals
n/a
426 426100000
459 458800000
611 610700000
597 597100000
549 548500000
615 614500000
624 623700000
1,131 1130500000
Accounts Payable
n/a
160 159700000
183 183100000
258 257800000
258 257800000
237 236900000
305 304500000
282 282300000
497 497400000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
266 266400000
276 275700000
353 352900000
339 339300000
312 311600000
310 310000000
341 341400000
633 633100000
Short Term Debt
n/a
121 120800000
417 417200000
362 361700000
136 135500000
480 480000000
111 111300000
347 347100000
424 423900000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
10 9900000
6 5500000
146 146100000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
146 146100000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
10 9900000
6 5500000
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
547 546900000
876 876000000
972 972400000
733 732600000
1,029 1028500000
736 735700000
976 976300000
1,701 1700500000
Long Term Debt
n/a
1,601 1600500000
977 977200000
1,827 1826700000
2,086 2085500000
2,175 2175000000
2,889 2889100000
2,683 2682700000
5,940 5940300000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
713 712500000
736 736100000
754 753700000
770 770000000
853 853400000
830 830400000
805 804600000
1,558 1558100000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
523 522900000
578 577700000
602 602300000
478 477900000
546 546000000
564 563900000
530 530400000
1,235 1235000000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
190 189600000
158 158400000
151 151400000
292 292100000
307 307400000
267 266500000
274 274200000
323 323100000
Total Noncurrent Liabilities
n/a
2,313 2313000000
1,713 1713300000
2,580 2580400000
2,856 2855500000
3,028 3028400000
3,720 3719500000
3,487 3487300000
7,498 7498400000
Total Liabilities
n/a
2,860 2859900000
2,589 2589300000
3,553 3552800000
3,588 3588100000
4,057 4056900000
4,455 4455200000
4,464 4463600000
9,199 9198900000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
250 250200000
49 49200000
66 66100000
12 11700000
11 11300000
11 10500000
10 10400000
1,987 1986500000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-930 -929800000
-933 -932500000
-935 -934900000
-941 -940900000
-952 -951800000
-959 -958900000
-966 -965500000
-978 -978100000
Retained Earnings
n/a
2,385 2384600000
2,928 2927900000
3,247 3246600000
3,387 3387200000
3,589 3588500000
3,374 3373500000
3,786 3786100000
4,223 4223000000
Other Equity
n/a
-17 -16700000
62 61500000
89 88500000
46 45500000
69 69400000
66 66200000
-11 -10500000
-367 -367400000
Equity Before Minority Interest
n/a
1,688 1688300000
2,106 2106100000
2,466 2466300000
2,504 2503500000
2,717 2717400000
2,491 2491300000
2,821 2820500000
4,864 4864000000
Minority Interest
n/a
121 121300000
142 142400000
169 168700000
20 20200000
21 20700000
19 19400000
18 17700000
15 14900000
Total Equity
n/a
1,810 1809600000
2,249 2248500000
2,635 2635000000
2,524 2523700000
2,738 2738100000
2,511 2510700000
2,838 2838200000
4,879 4878900000
Total Liabilities & Equity
n/a
4,670 4669500000
4,838 4837800000
6,188 6187800000
6,112 6111800000
6,795 6795000000
6,966 6965900000
7,302 7301800000
14,078 14077800000
Remarks restated on n/a restated on Feb 24, 2010 n/a restated on Mar 7, 2011 n/a restated on Feb 24, 2012 n/a restated on Feb 26, 2013 n/a restated on Feb 25, 2014 n/a restated on Feb 26, 2015 n/a restated on Mar 1, 2016 n/a restated on Oct 28, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
477
478
556
572
533
585
575
513
438
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
163
180
195
204
231
230
230
246
458
Non-Cash Items
65
118
59
69
64
102
88
57
115
Stock-Based Compensation
35
36
36
40
49
41
37
46
102
Deferred Income Taxes
27
70
10
13
2
53
56
28
-33
Other Non-Cash Adjustments
3
12
13
16
13
8
-6
-16
46
Change in Working Capital
6
6
53
39
28
-75
-75
-76
-29
(Increase) Decrease in Accounts Receivable
-79
28
74
-25
-37
1
-68
-31
-72
(Increase) Decrease in Inventories
5
-9
-4
-6
-6
-6
-15
0
0
Increase (Decrease) in Accounts Payable
34
16
23
50
-9
-30
61
-21
31
Increase (Decrease) in Other
46
-30
-40
20
79
-39
-53
-24
13
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
710
781
862
884
856
841
819
739
982
Change in Fixed Assets & Intangibles
-142
-157
-114
-122
-142
-173
-201
-202
-255
Disposition of Fixed Assets & Intangibles
1
1
1
5
4
3
1
1
1
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
-1
-1
0
0
0
-3
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
-1
-1
0
0
0
-3
0
0
0
Other Change in Fixed Assets & Intangibles
-143
-157
-115
-126
-146
-174
-202
-204
-256
Net Change in Long Term Investment
0
0
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-222
-345
-217
-1,191
-138
-361
-159
-148
-3,740
Net Cash from Divestitures
0
0
0
0
0
0
8
32
8
Cash for Acqusition of Subsidiaries
0
0
-4
-10
0
-26
-7
-20
-12
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
-222
-345
-213
-1,181
-138
-335
-160
-159
-3,736
Other Investing Activities
26
110
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-339
-392
-331
-1,313
-280
-534
-360
-350
-3,995
Dividends Paid
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
465
49
-342
787
29
432
328
-20
3,109
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-844
-269
-248
-255
-526
-431
-842
-154
99
Increase in Capital Stock
78
64
25
83
118
86
174
115
99
Decrease in Capital Stock
-921
-334
-273
-338
-644
-517
-1,016
-269
0
Other Financing Activities
12
-2
-14
-22
-149
-2
-5
-26
-24
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-367
-223
-604
511
-645
-1
-518
-201
3,185
Net Cash Before Disc. Operations and FX
5
166
-73
81
-70
306
-59
188
172
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
5
166
-73
81
-70
306
-59
188
172
Effect of Foreign Exchange Rates
0
-3
1
1
-2
1
-4
-12
-36
Net Changes in Cash
5
163
-71
82
-71
308
-63
176
136
Remarks
restated on Feb 24, 2010 n/a
calculated values,
restated on Mar 7, 2011 n/a
calculated values,
restated on Feb 24, 2012 n/a
calculated values,
restated on Feb 26, 2013 n/a
calculated values,
restated on Feb 25, 2014 n/a
calculated values,
restated on Feb 26, 2015 n/a
calculated values,
restated on Mar 1, 2016 n/a
calculated values,
restated on Mar 1, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo